Physician profile
Nelson E Bennett
NPI 1366529240
$37,045.62
in general payments reported to CMS, 2019-2025
8 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $381 · 2021: $432 · 2022: $7,644 · 2023: $5,628 · 2024: $2,943 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,690 · Travel and Lodging: $2,645 · Honoraria: $700 · Food and Beverage: $680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,690.00 |
| Travel and Lodging | $2,644.56 |
| Honoraria | $700.00 |
| Food and Beverage | $679.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $25,245.64 | 2019-2023 | Xiaflex |
| Coloplast Corp | $10,777.91 | 2019-2025 | Titan |
| Cook Incorporated | $700.00 | 2023 | |
| Boston Scientific Corporation | $213.73 | 2022 | |
| Antares Pharma, INC. | $50.00 | 2022 | |
| Endo USA, INC. | $32.21 | 2025 | Xiaflex |
| Hollister Incorporated | $13.92 | 2022 | |
| Metuchen Pharmaceuticals | $12.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nelson Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.